ClearLight Diagnostics licenses IP rights for tissue processing and imaging technologies

    Sept. 18, 2015
    ClearLight Diagnostics has signed a license agreement for the rights covering inventions relating to tissue imaging and processing.

    ClearLight Diagnostics (Sunnyvale, CA), which develops tools and technologies for analyzing and imaging tissue samples, has signed an exclusive, worldwide license agreement with Stanford University (CA) for the intellectual property rights covering inventions relating to tissue imaging and processing.

    Related: Deeper focus in microscopic bioimaging

    The licensed technologies involve CLARITY, a tissue transparentizing method, and CLARITY Optimized Light-sheet Microscopy (COLM), a new optics system for accelerating image collection from clarified samples.

    ClearLight is initially funded by a syndicate created by Wiegers Capital Partners LLC, and plans to commercialize products and services based on the licensed technologies.

    Continue Reading

    Sponsored Recommendations

    March 31, 2025
    Enhance your remote sensing capabilities with Chroma's precision-engineered optical filters, designed for applications such as environmental monitoring, geospatial mapping, and...
    March 31, 2025
    Designed for compatibility with a wide range of systems, Chroma's UV filters are engineered to feature high transmission, superior out-of-band blocking, steep edge transitions...
    March 31, 2025
    Discover strategies to balance component performance and system design, reducing development time and costs while maximizing efficiency.
    March 31, 2025
    Filter accessories including cubes, sliders, and rings, designed to enhance the performance and versatility of optical systems. These components ensure precise alignment and stability...

    Voice your opinion!

    To join the conversation, and become an exclusive member of Laser Focus World, create an account today!